Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Phonetica|January 1, 1987
Two magnetic methods for articulatory measurementsG Panagos, H W Strube
Clinics in Perinatology|August 14, 2017
Creating a Highly Reliable Neonatal Intensive Care Unit Through Safer Systems of CarePatoula G Panagos, Stephen A Pearlman
European Journal of Gynaecological Oncology|January 1, 1994
Immunohistochemical expression of EGF-R in malignant surface epithelial ovarian neoplasms (SEON)J Janinis, L Nakopoulou, G Panagos, et al.
Clinics in Perinatology|August 14, 2017
Reducing Incidence of Necrotizing EnterocolitisAloka L Patel, Patoula G Panagos, Jean M Silvestri
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 6, 2007
Correlation of tissue transglutaminase expression on breast cancer tissue with time to relapse, overall survival, and clinical and molecular prognostic factors: a preliminary reportE Kyparidou, A Athanasiadis, E Xydakis, et al.
Carbohydrate Polymers|February 16, 2016
Photochemical depolymerisation of dermatan sulfate and analysis of the generated oligosaccharidesCharalampos G Panagos, David P August, Christine Jesson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The immunohistochemical expression of proliferating cell nuclear antigen (PCNA/cyclin) in malignant and benign epithelial ovarian neoplasms and correlation with prognosisL Nakopoulou, J Janinis, G Panagos, et al.
Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses|February 4, 2021
Engaging Frontline Providers Prevents Hypothermia and Improves Communication in the Postoperative NeonateJudith C Guidash, Loren Berman, Patoula G Panagos, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 20, 2007
Second line chemotherapy with methotrexate and gemcitabine in patients with relapsing head and neck cancerE Xydakis, E Repassos, M Poulou, et al.
American Journal of Clinical Oncology|April 25, 2000
Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer: a phase II feasibility studyJ Janinis, M Papadakou, E Xidakis, et al.
Pageof 3